What the Delta variant could mean for the Pfizer vaccine


As the Delta variant of COVID-19 makes its way across the globe, a new report from Israeli website Ynet has some good news about the Pfizer-BioNTech vaccine — and some bad. First, the good news: Data from the Israel Health Ministry find the vaccine holds up well against the variant when it comes to hospitalizations and serious illness, with an efficacy rate of 93 percent according to data from June 6 to July 3, when the Delta variant really began to take hold, Bloomberg reports. That's down from 98.2 percent compared to the variants that came before, but still very good.
The bad news is the data appear to indicate a significant drop in efficacy when it comes to the Pfizer vaccine preventing infection overall. Between May 2 and June 5, the vaccine had a 94.3 percent efficacy rate at preventing infection, Bloomberg explains. That rate dropped to 64 percent in the month that followed.
If the data are correct, it means that even if you're fully vaccinated, you could still catch and show symptoms of COVID-19. That's always been the case, but the Delta variant makes it more likely. But the immunization still significantly reduces your chances of landing in the hospital.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The Delta variant is dominant in many parts of the United States, and some states' health-care systems are already under pressure, Financial Times reports. The Pfizer vaccine is one of three COVID-19 vaccines authorized for use in the U.S.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Jessica Hullinger is a writer and former deputy editor of The Week Digital. Originally from the American Midwest, she completed a degree in journalism at Indiana University Bloomington before relocating to New York City, where she pursued a career in media. After joining The Week as an intern in 2010, she served as the title’s audience development manager, senior editor and deputy editor, as well as a regular guest on “The Week Unwrapped” podcast. Her writing has featured in other publications including Popular Science, Fast Company, Fortune, and Self magazine, and she loves covering science and climate-related issues.
-
Hyatt Regency Lisbon: a tranquil oasis in the historic district of Belém
The Week Recommends With its sprawling spa and prime location overlooking the River Tagus, this luxury hotel is a great place to escape the bustle of the city
-
Quiz of The Week: 6 – 12 September
Quiz Have you been paying attention to The Week's news?
-
The week’s best photos
In Pictures A palace on fire, a shopping cart protest, and more
-
SpaceX breaks Starship losing streak in 10th test
speed read The Starship rocket's test flight was largely successful, deploying eight dummy satellites during its hour in space
-
Rabbits with 'horns' sighted across Colorado
speed read These creatures are infected with the 'mostly harmless' Shope papilloma virus
-
Lithium shows promise in Alzheimer's study
Speed Read Potential new treatments could use small amounts of the common metal
-
Scientists discover cause of massive sea star die-off
Speed Read A bacteria related to cholera has been found responsible for the deaths of more than 5 billion sea stars
-
'Thriving' ecosystem found 30,000 feet undersea
Speed Read Researchers discovered communities of creatures living in frigid, pitch-black waters under high pressure
-
New York plans first nuclear plant in 36 years
Speed Read The plant, to be constructed somewhere in upstate New York, will produce enough energy to power a million homes
-
Dehorning rhinos sharply cuts poaching, study finds
Speed Read The painless procedure may be an effective way to reduce the widespread poaching of rhinoceroses
-
Breakthrough gene-editing treatment saves baby
speed read KJ Muldoon was healed from a rare genetic condition